Dr. Reddy's Laboratories
RDY
#1699
Rank
C$16.39 B
Marketcap
C$19.60
Share price
0.35%
Change (1 day)
-2.77%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Cash on Hand

Cash on Hand as of September 2025 : C$1.08 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company has C$1.08 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Dr. Reddy's Laboratories - Cash on Hand chart (from 2001 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31C$0.97 B-26.22%
2024-03-31C$1.32 B29.86%
2023-03-31C$1.01 B39.31%
2022-03-31C$0.73 B23.1%
2021-03-31C$0.59 B23.35%
2020-03-31C$0.48 B1.08%
2019-03-31C$0.47 B14.62%
2018-03-31C$0.41 B11.58%
2017-03-31C$0.37 B-52.5%
2016-03-31C$0.78 B-2.97%
2015-03-31C$0.80 B30.7%
2014-03-31C$0.61 B49.2%
2013-03-31C$0.41 B16.15%
2012-03-31C$0.35 B183.61%
2011-03-31C$0.12 B-45.4%
2010-03-31C$0.23 B51.01%
2009-03-31C$0.15 B-50.52%
2008-03-31C$0.30 B-36.29%
2007-03-31C$0.48 B393.2%
2006-03-31C$98.06 M-63.38%
2005-03-31C$0.26 B28.26%
2004-03-31C$0.20 B-6.78%
2003-03-31C$0.22 B34.29%
2002-03-31C$0.16 B932.98%
2001-03-31C$16.14 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
C$20.70 B 1,806.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$3.04 B 180.35%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
C$6.13 B 465.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
C$13.47 B 1,141.16%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
C$14.43 B 1,230.10%๐Ÿ‡ซ๐Ÿ‡ท France